Good study, large, good results, independent.
Shows the value of not mucking about initially and just going straight to BTM prior to STSG - integration of skin graft was more successful when BTM was used, and integration of BTM was much more successful when it was used first off - less successful if grafts were attempted and failed initially.
This is great. Good work PNV. The product works.
The Clinicians Speak, page-898
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.34 |
Change
-0.020(0.85%) |
Mkt cap ! $1.615B | |||
| Open | High | Low | Value | Volume |
| $2.34 | $2.37 | $2.32 | $2.004M | 857.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2441 | $2.33 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.34 | 19571 | 5 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.33 |
Change
-0.020 ( 1.24 %) |
||||
| Open | High | Low | Volume | ||
| $2.34 | $2.37 | $2.32 | 261156 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| PNV (ASX) Chart |